SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant attention as investors anticipate a major shift in institutional demand driven by the upcoming Russell Index reconstitution, which necessitates mandatory buying from passive funds. The community is actively tracking potential catalysts, including regulatory updates and revenue performance, while discussing how these factors might counteract persistent short-selling pressure.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending after announcing a multi-year joint research agreement with Honda to advance solid-state battery technology, validating the company's tech platform with a second major OEM. The community is actively discussing the strategic significance of this partnership, comparing it to ongoing collaborations with other automotive giants while debating the path toward commercial-scale manufacturing.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to reports of inevitable memory price hikes from industry leaders, fueling excitement over an AI-driven memory supercycle that has sent the stock to record highs. Community discourse is polarized between bulls celebrating institutional accumulation and historic momentum, and bears warning that current valuation levels and RSI extremes signal an impending bubble burst.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing significant momentum driven by growing institutional interest and high expectations for upcoming Phase 3 trial data in non-small cell lung cancer (NSCLC) and the upcoming BLA filing. Community discourse is heavily focused on the stock's potential as a buyout target, with many participants viewing the current valuation as disconnected from the company's clinical progress and platform potential.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending due to strong demand for its fuel cell solutions as AI data centers face urgent power grid constraints. The community is actively discussing the company's massive contract backlog and its emergence as a critical backbone for AI infrastructure.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is generating significant market interest following a series of technical breakthroughs, including FDA clearance for an AI-powered gestational age tool and expanded government cloud authorizations. While community sentiment is divided between long-term investors tracking institutional backing and technical advancements, and traders wary of profit-taking pullbacks, the stock is trending as participants monitor its potential as an AI-driven platform play in the medical technology sector.

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clover Health is currently driving intense community discussion following a positive CMS star rating upgrade and court ruling, fueling speculation about potential institutional interest and long-term valuation shifts. Investors are actively debating the stock's consolidation around the five-dollar psychological threshold as they monitor short interest trends and potential upcoming SaaS partnerships.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors aggressively build positions ahead of its upcoming Nasdaq-100 inclusion, driving the stock to fresh all-time highs amidst broad institutional interest in AI infrastructure. Community sentiment remains highly polarized, with intense debates between bulls betting on a structural breakout and bears arguing that the valuation has become decoupled from fundamental financial performance.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum (HQ) is seeing intense volatility and aggressive buy-side momentum, fueled by its low public float and strategic backing from major industry players like IonQ and Dell. Investors are currently fixated on the company's positioning as a software-centric 'picks and shovels' play in the quantum computing sector, with many discussing the potential for a short squeeze despite concerns over insider ownership and potential dilution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing increased investor optimism driven by positive clinical data for its subcutaneous Briumvi treatment and mounting speculation of a potential buyout from a major pharmaceutical player. The community is actively discussing the company's strong growth momentum, the potential for market share expansion in new indications, and the aggressive positioning of short sellers against a backdrop of institutional accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

American Century ETF Trust - Avantis Short-Term Fixed Income ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

AVSFAmerican Century ETF Trust - Avantis Short-Term Fixed Income ETF

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest AVSF News